September 11, 2019 - Volv Global’s inTrigue AI algorithms identify diagnostic signals from patient medical record data and help patients receive treatment earlier by enabling earlier diagnosis, particularly of rare and difficult to diagnose diseases. The partnership brings this capability to the Patient Network Explorer platform, which comprises patient data from across Clinerion’s global network of hospital partners. Use of Volv’s inTrigue AI algorithms on Patient Network Explorer will allow more intelligent and earlier identification of disease onset among patients in Clinerion’s network, and therefore earlier therapeutic and clinical treatment to many more patients.
Clinerion partners with Volv Global to bring treatment earlier to patients by enhancing diagnosis search on Patient Network Explorer with inTrigue AI algorithms.
The partnership between Clinerion and Volv Global brings benefits to patients by combining Volv’s uniquely accurate cohort identification algorithms with Clinerion’s growing data network of hospitals around the world. The Volv and Clinerion partnership will deploy Volv’s inTrigue algorithms across many more hospitals and this will create tangible outcomes for patients who suffer from late diagnosis of between seven and 15 years, as well as from misdiagnosis and subsequent increased disease burden.